Radicle ACES investigates CBD efficacy
Green Rock Hemp Holdings, a vertically integrated grower, processor and marketer of hemp derivatives, recently announced that PURAURA Naturals, an Enhanced Botanicals brand, will be participating in the groundbreaking Radicle ACES (Advancing CBD Education and Science) study. Using a virtual, direct to consumer approach, Radicle ACES is the largest and most comprehensive randomized controlled trial of its kind, collecting data on 13 commercial brands and nearly 3,000 participants.
During the four-week study, participants will use the Radicle Science platform to track consumption and effectiveness of orally ingested CBD products on well-being, quality of life, pain, sleep disturbance, and anxiety. Radicle ACES will use validated, standardized health indices to gather health outcome data from a diverse population across a variety of geographies, ethnicities, age groups, behavioral habits, and pre-existing health conditions.
“A rigorous scientific study of this magnitude has never before been conducted in the CBD market,” said Pelin Thorogood, Co-founder and Executive Chair of Radicle Science. “Radicle ACES is driven by our deep commitment to contribute to the body of evidence to support growing demand from consumers and healthcare providers. Given the scale, the diversity of the participant population and the wide range of high-quality commercial brands included, Radicle ACES promises to deliver rich, objective health outcome data for a variety of common health conditions, with the potential to offer unprecedented guidance on CBD effectiveness based on demographic or behavioral differences.”
“The Radicle ACES study is groundbreaking, as it will move the CBD industry from anecdotal evidence regarding product efficacy to concrete scientific data,” stated Joseph Cachey, Chief Executive Officer, Green Rock Hemp Holdings. “Radicle has unparalleled experience leading research on Cannabinoids, so the study will be based on integrity and transparency,” he added. “These are the same principles shared by Enhanced Botanicals — integrity of raw materials, transparency in ingredients and testing, and consistency in developing high quality products our customers can count on.”
The Real-World Evidence collected will inform scientific understanding on dosing, usage patterns, user characteristics, effectiveness across conditions, and predictors and modifiers of treatment response. “We’re applying science to understand the effectiveness of CBD products used by tens of millions of Americans every day,” said Jeff Chen, MD/MBA, Co-founder and CEO of Radicle Science. “We’re partnering with 13 leading CBD brands and collaborators across five top tier research universities to drive accurate, transparent, and actionable insights for all stakeholders.”
Radicle ACES findings will address the top two barriers to CBD usage identified in a 2019 Nielsen study: 1) difficulty gauging effectiveness of specific products, and 2) lack of research data on health benefits. Anonymized aggregate results will be released in October 2021.
For more background on Radicle ACES methodology and additional insights from collaborators and experts involved in the study, see this Radicle Resources article.